FDA Adverse Event Malfunction Summary report: N

SWEET PICOTIP

MDR report key: 6698575 · Received July 10, 2017

Report

Report Number
2124215-2017-07552
Event Type
Malfunction
Date Received
July 10, 2017
Date of Event
April 21, 2017
Report Date
May 24, 2017
Manufacturer
CPI - DEL CARIBE
Product Code
DTB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A GENERATOR CHANGEOUT PROCEDURE THIS RIGHT ATRIAL (RA) LEAD SEPARATED FROM THE TERMINAL PIN. IT WAS STATED THAT AFTER TIGHTENING THE SETSCREW AND TUGGING ON THE LEAD IT CAME APART AT THE TERMINAL PIN. THE LEAD WAS STILL CONNECTED BY THE WIRE AND CONTINUED TO CAPTURE AND SENSE; HOWEVER, THE IMPEDANCES WERE VARIABLE BETWEEN 200-700 OHMS. IT WAS REPORTED THAT A LEAD SAFETY SWITCH (LSS) HAD BEEN TRIPPED. PROGRAMMING MODIFICATION WERE MADE. THE PHYSICIAN WAS USING LOCAL ANESTHESIA AND THE PATIENT HAD EATEN BEFOREHAND THEREFORE, THE PHYSICIAN DIDN'T WANT TO REVISE OR TAKE FURTHER ACTION AT THAT TIME. THE PATIENT PACED 80% OF THE TIME IN THE ATRIUM. NO ADVERSE PATIENT EFFECTS WERE REPORTED. NO FURTHER ACTIONS HAVE BEEN PERFORMED AND THE PHYSICIAN PLANS TO MONITOR VIA THE REMOTE MONITORING SYSTEM.

Description of Event or Problem · 1

ADDITIONAL INFORMATION INDICATES THAT THIS LEAD WAS NOW EXHIBITING NOISE, INCREASED PACING THRESHOLDS AND POCKET STIMULATION. THE STIMULATION MAKES THE PATIENT UNCOMFORTABLE. THE LEAD CONTINUES TO TRIPPED LEAD SAFETY SWITCHES (LSS). THE PHYSICIAN PROGRAMMED THE PATIENT'S DEVICE TO SENSE AND PACE IN THE VENTRICLE ONLY AT 40 AND SENT THE PATIENT FOR X-RAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
478446 SWEET PICOTIP IMPLANTABLE LEAD DTB CPI - DEL CARIBE 4053

Patients

Seq Age Sex Outcome Treatment
1 84 YR 1280| 4053| 4054| L321| S603